By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Silence Therapeutics plc 

Centre Point
103 New Oxford Street
London    WC 1A 1DD  United Kingdom
Phone: 44-0-20-73071620 Fax: 44-0-20-73071680



Company News
Silence Therapeutics Release: Interim Results For The Six Months Ended 30 June 2016 9/27/2016 10:25:40 AM
Silence Therapeutics Release: Director’s Dealings 4/19/2016 11:18:24 AM
Silence Therapeutics Release: Board Changes 1/18/2016 9:12:20 AM
Silence Therapeutics Release: Board Appointment 11/12/2015 9:50:43 AM
Silence Therapeutics Interim Results For The Six Months Ended 30 June 2015 9/29/2015 9:22:28 AM
MiReven, Silence Therapeutics plc Ink Collaboration 8/22/2012 11:00:58 AM
Silence Therapeutics plc - Admission of Shares and Board Update 8/2/2012 1:10:23 PM
Silence Therapeutics plc Announces Safe and Effective Dose Successfully Identified in Phase I Study of Atu027 and Potential Fund Raising 6/6/2012 11:01:30 AM
New Data from Silence Therapeutics plc's Atu027 Anticancer Trial Published at American Society of Clinical Oncology 5/17/2012 10:47:40 AM
Silence Therapeutics plc' Partner, Quark Pharmaceuticals Inc., Extends its Agreement With Pfizer Inc. (PFE) to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 5/3/2012 7:02:19 AM